Evidence map›Paper›PMID 3141553›Full record

ArticleThe Journal of experimental medicine1988

Alternative V kappa gene rearrangements in a murine B cell lymphoma. An explantation for idiotypic heterogeneity.

W L Carroll, C O Starnes, R Levy, S Levy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  2. Article
  3. Article
  4. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

W L CarrollDepartment of Medicine, Stanford University School of Medicine, California 94305.
C O Starnes
R Levy
S Levy
Stanford University · US

Funding

TRIGGERING CELL DEATH IN B CELL LYMPHOMAP01CA034233 · NCI · STANFORD UNIVERSITY · PI FELSHER, DEAN W · 1985 to 2010
$19.5M
ANTIIDIOTYPE THERAPY OF HUMAN B CELL MALIGNANCYR37CA033399 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 1988 to 2007
$4.5M
NCI CLINICAL INVESTIGATOR AWARD PROGRAMK08CA001059 · NCI · WASHINGTON UNIVERSITY · PI CARROLL, WILLIAM L. · 1985 to 1987
–
HUMAN ANTITUMOR THERAPY WITH MONOCLONAL ANTIBODIESR01CA033399 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD · 1985 to 1998
–
NCI NIH HHS CA-01059NCI NIH HHS CA-33399NCI NIH HHS CA-34233
6 · The paper itself

Abstract

Idiotype variants of 38C13, a murine B cell lymphoma, have been isolated by immunoselection with antiidiotype mAbs. The V region genes for the kappa light chains and mu heavy chains expressed by these tumor cells were sequenced and compared. There was no evidence for V region somatic point mutation in this tumor. However, while the heavy chain genes were all identical, the light chain genes were all different. The light chain genes of each variant were derived from the V kappa-Ox1 gene family and joined to J kappa 4, whereas the light chain gene of the parental tumor was derived from the V kappa 9 family and joined to J kappa 2. Two of the variants used the identical V kappa gene but differed by the inclusion of a variable number of additional nucleotides in the V/J joint. Thus, the idiotypic heterogeneity of this B cell lymphoma arises as a consequence of alternative light chain rearrangements rather than point mutation. This process repetitively uses members of the same V kappa gene family. Two of the variants use the identical V kappa and J kappa gene segments but differ by the presence of extra nucleotides at the V kappa/J kappa joint.

Indexed as

Gene Rearrangement, B-Lymphocyte, Light ChainGenes, ImmunoglobulinAmino Acid SequenceAnimalsBase SequenceB-LymphocytesImmunoglobulin Heavy ChainsImmunoglobulin IdiotypesImmunoglobulin kappa-ChainsImmunoglobulin Variable RegionLymphomaMiceMice, Inbred C3HMolecular Sequence DataImmunoglobulin Heavy ChainsImmunoglobulin IdiotypesImmunoglobulin kappa-ChainsImmunoglobulin Variable Region

Identifiers

PMID3141553
PMCPMC2189115
OpenAlexW2130719741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.